Enerzair Breezhaler 150/50/160 μg
As listed in the register: Enerzair Breezhaler 150/50/160 μg, Hartkapsel mit Pulver zur Inhalation
160 μg ·
- Prescription only
- Breathing, airways, allergies and cough
- Active substance
- Indacaterolum + Glycopyrronium + Mometasoni furoas
- Made by
- Novartis Pharma Schweiz AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Asthma
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Novartis Pharma Schweiz AG |
|---|---|
| Active substance | Indacaterolum + Glycopyrronium + Mometasoni furoas |
| Used in | Breathing, airways, allergies and cough |
| Strength | 160 μg |
| Classification | R03AL12 · Breathing, airways, allergies and cough |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Enerzair Breezhaler 150/50/160 μg, Hartkapsel mit Pulver zur Inhalation |
| Packs | 30 Kapsel(n) · 90 Kapsel(n) |
| Zulassungsnummer | 67596 |
| Dosisstärke | 2 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.